13. October 2017
The majority of New Chemical Entitities (NCEs) being considered for therapeutic applications are BCS Class II, Class III, or Class IV, indicating that these potential Active Pharmaceutical Ingredients (APIs) will exhibit solubility and/or permeability challenges. Functional lipids are one of the most widely employed excipient classes utilized in overcoming both solubility and permeability challenges. Many API’s which are insoluble in aqueous media can be emulsified in functional lipids...
17. April 2015
By Gareth MacDonald+, 16-Apr-2015 BASF, Abitec and Gattefossé dominate the solubility excipients market but growing demand for tech to enhance API solubility is creating opportunities for smaller suppliers according to new research. http://www.in-pharmatechnologist.com/Drug-Delivery/Big-firms-dominate-solubility-sector-but-demand-creating-space-for-small-players-says-Kline-Co